InflaRx NV (IFRX) - Margin dodolan resik

inflarx.de (IFRX) - logo korporat

The non-cyclical nature of immunotherapy development and close cooperation with US distributors ensure the stability of InflaRx N.V. (IFRX). The net profitability profile of sales demonstrates the business's adaptation to borrowing costs, with the value stabilizing at 0.00. The German biotech firm is developing C5a inhibitors to combat severe inflammation in intensive care units, targeting the therapy of pyoderma gangrenosum.

Margin resik inflarx.de (IFRX): kanggo periode 04.07.2022 - 19.11.2026

InflaRx NV (IFRX) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi pasar:
Ringkesan analisis perusahaan:inflarx.de, IFRX
Produk asil prodhuksi InflaRx

To protect capital during periods of volatility, assessing a business's ability to generate net profit from every dollar of revenue is critical. This ratio measures the remaining funds after covering all operating and tax obligations. By analyzing the commercial profit margin of InflaRx N.V. (IFRX), an investor can determine how quickly margins adapt to cost inflation. For InflaRx N.V. (IFRX), this serves as a survival indicator in the struggle against biotech behemoths for government protocols. Sharp fluctuations in the trend line signal a risk of losing competitiveness against universal immunoblockers.

Karo sapa InflaRx N.V. saingan

argenx (ARGX) - Margin resik|BNTX - Margin dodolan perusahaan|ABVX (Abivax Pharma) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ADMA Bio (ADMA)|Rentabilitas dodolan miturut bathi resik PTGX (Protagonist Therapeutics Inc)|Margin dodolan resik immunovant.com (IMVT)|Margin resik kiniksa.com KNSA|Grifols SA (GRFS) - Margin resik|Adaptive Biotechnologies Inc. - Margin dodolan resik|Margin resik Celldex Therapeutics|AUPH: Margin dodolan resik|BCRX - Margin dodolan perusahaan|VERA (Vera Corp) - Margin dodolan resik|Dianthus Pharma (DNTH) - Margin dodolan perusahaan|Margin resik Pharvaris Pharma (PHVS)|Margin dodolan resik AbCellera Corp (ABCL)|Margin dodolan resik TRML (Tourmaline Bio Inc)|Margin dodolan perusahaan precigen.com (PGEN)|PHAR - Margin resik|Tingkat bathi resik NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Rentabilitas dodolan miturut bathi resik|Zenas Corp (ZBIO) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik IMNM|GOSS: Tingkat bathi resik|Margin resik KalVista Pharma (KALV)|SEPN - Margin resik|Margin dodolan resik PVLA (pieris.com)|Margin dodolan resik Savara Pharma SVRA|RIGL: Rentabilitas dodolan miturut bathi resik|ANAB - Margin dodolan resik|ATXS: Margin dodolan resik|ENGN - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RAPT|JBIO (Aerovate Therapeutics Inc) - Rentabilitas resik perusahaan|Margin dodolan resik ACRS|Rentabilitas dodolan miturut bathi resik kyvernatx.com KYTX|Margin dodolan resik TLSA (Tiziana Life Sciences, Ltd.)|Margin dodolan resik Cabaletta Bio CABA|VTYX: Rentabilitas dodolan miturut bathi resik|Theratechnologies Inc. (THTX) - Rentabilitas dodolan miturut bathi resik|AVTX: Margin dodolan resik|ELDN - Margin dodolan perusahaan|AGEN (Agenus, Inc) - Margin dodolan resik|Margin dodolan resik Climb Bio, Inc.|Margin resik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Tingkat bathi resik|Margin dodolan resik ADAG (Adagene Inc)|IMA - Rentabilitas dodolan miturut bathi resik|STTK - Margin resik|EQ (equilliumbio.com) - Rentabilitas dodolan resik|CNTB: Margin dodolan resik|Immunic Inc (IMUX) - Margin dodolan resik|ATRA (Atara Biotherapeutics Inc) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik x4pharma.com (XFOR)|Margin dodolan resik ACET|Rentabilitas dodolan miturut bathi resik Celularity Corp CELU|INmune Bio Inc - Rentabilitas dodolan miturut bathi resik|BRNS (Barinthus Bio) - Margin bathi resik|KZR - Margin resik|Margin dodolan perusahaan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Margin resik|ENLV - Margin dodolan perusahaan|QTTB (Q32 Bio) - Margin dodolan resik|Margin resik GeoVax Labs Inc GOVX|Margin resik Edesa Biotech (EDSA)|Rentabilitas dodolan miturut bathi resik iBio IBIO|Carisma Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|XTLB - Rentabilitas dodolan miturut bathi resik|BOLT - Margin resik|Tingkat bathi resik HCWB (hcwbiologics.com)|APVO: Margin dodolan resik|aimimmuno.com (AIM) - Margin dodolan resik|Margin resik aditxt.com|Rentabilitas dodolan miturut bathi resik GRI Bio Corp (GRI)|Margin resik XORTX Therapeutics Inc. (XRTX)|Rentabilitas dodolan miturut bathi resik ReShape Lifesciences HIND|Margin resik Revelation Biosciences REVB|INDP: Rentabilitas dodolan resik|SCNI - Margin resik|CALI (calcimedica.com) - Rentabilitas dodolan resik|AFMD (Affimed Therapeutics) - Rentabilitas dodolan miturut bathi resik|Allakos Therapeutics (ALLK) - Margin dodolan resik|HOOK (HOOKIPA) - Margin dodolan resik|igmbio.com (IGMS) - Margin dodolan perusahaan|Margin dodolan resik ITOS|OCEA (Ocean Biomedical) - Tingkat bathi resik|Margin dodolan resik TCBP (TC BioPharm (Holdings) PLC)|THRD - Rentabilitas dodolan miturut bathi resik